Journal of Clinical Endocrinology & Metabolism, Vol 78, 592-596, Copyright © 1994 by Endocrine Society

ARTICLES

Immunohistochemical localization of transforming growth factor-beta in human implantation sites

CE Selick, GM Horowitz, M Gratch, RT Scott Jr, D Navot and GE Hofmann
Department of Obstetrics and Gynecology, Mount Sinai Medical Center, New York, New York 10029.

Transforming growth factor-beta (TGF beta), a protein known to antagonize many of the functions of the epidermal growth factor- receptor system, was localized immunohistochemically in unruptured ectopic pregnancies (EP) removed by salpingectomy (n = 8), uterine decidua from EP (n = 4), and decidua and trophoblast from electively terminated first trimester pregnancies (ETP; n = 8). Two rabbit polyclonal antisera that recognize both TGF beta 1 and beta 2 were used. Immunostaining for TGF beta was identified in all three forms of trophoblast, cytotrophoblasts, intermediate trophoblasts, and syncytiotrophoblasts, which were differentiated histologically and immunohistochemically. Moderate cytoplasmic immunostaining was found in villous cytotrophoblasts in both EP and ETP. Nonvillous (anchoring) cytotrophoblasts in these same tissues demonstrated moderate immunostaining adjacent to the villous and light immunostaining distal to the villous. In intermediate trophoblasts, moderate to intense immunostaining was seen in EP and ETP. Syncytiotrophoblasts demonstrated moderate cytoplasmic immunostaining in EP and ETP as well as moderate to intense staining of plasma membranes and microvilli. Nuclear staining was not evident in any form of trophoblast. TGF beta immunostaining was demonstrated in both glands and stroma of decidua from both EP and ETP; however, staining was more intense in decidua from ETP. With the known presence of TGF beta receptors and mRNA in placenta, these results suggest an autocrine/paracrine role for TGF beta regulation of endometrial-trophoblast function during human implantation.

This article has been cited by other articles:

				R. L Jones, C. Stoikos, J. K Findlay, and L. A Salamonsen TGF-{beta} superfamily expression and actions in the endometrium and placenta. Reproduction, August 1, 2006; 132(2): 217 - 232. [Abstract] [Full Text] [PDF]

				M. J. Jasper, K. P. Tremellen, and S. A. Robertson Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue Mol. Hum. Reprod., May 1, 2006; 12(5): 301 - 308. [Abstract] [Full Text] [PDF]

				R. A. Vacca, E. Marra, G. Loverro, E. Maiorano, A. Napoli, M. Lovecchio, L. Selvaggi, and E. Perlino Differential Expression of {beta}1c Integrin Messenger Ribonucleic Acid and Protein Levels in Human Endometrium and Decidua during the Menstrual Cycle and Pregnancy J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 720 - 729. [Abstract] [Full Text] [PDF]

				U. A. Kayisli, B. Selam, R. Demir, and A. Arici Expression of vasodilator-stimulated phosphoprotein in human placenta: possible implications in trophoblast invasion Mol. Hum. Reprod., January 1, 2002; 8(1): 88 - 94. [Abstract] [Full Text] [PDF]

				O. Devergne, A. Coulomb-L'Hermine, F. Capel, M. Moussa, and F. Capron Expression of Epstein-Barr Virus-Induced Gene 3, an Interleukin-12 p40-Related Molecule, throughout Human Pregnancy : Involvement of Syncytiotrophoblasts and Extravillous Trophoblasts Am. J. Pathol., November 1, 2001; 159(5): 1763 - 1776. [Abstract] [Full Text] [PDF]

				F. Lyall, H. Simpson, J. Nicola Bulmer, A. Barber, and S. Courtenay Robson Transforming Growth Factor-{beta} Expression in Human Placenta and Placental Bed in Third Trimester Normal Pregnancy, Preeclampsia, and Fetal Growth Restriction Am. J. Pathol., November 1, 2001; 159(5): 1827 - 1838. [Abstract] [Full Text] [PDF]